Katia Varani
Katia Varani
Professore di Farmacologia, Universitā di Ferrara
Verified email at unife.it
TitleCited byYear
A glance at adenosine receptors: novel target for antitumor therapy
S Merighi, P Mirandola, K Varani, S Gessi, E Leung, PG Baraldi, ...
Pharmacology & therapeutics 100 (1), 31-48, 2003
2152003
The A3 adenosine receptor: an enigmatic player in cell biology
S Gessi, S Merighi, K Varani, E Leung, S Mac Lennan, PA Borea
Pharmacology & therapeutics 117 (1), 123-140, 2008
1982008
[3H] MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors
K Varani, S Merighi, S Gessi, KN Klotz, E Leung, PG Baraldi, B Cacciari, ...
Molecular Pharmacology 57 (5), 968-975, 2000
1652000
A3 Adenosine Receptor Ligands: History and Perspectives
PG Baraldi, B Cacciari, R Romagnoli, S Merighi, K Varani, PA Borea, ...
Medicinal research reviews 20 (2), 103-128, 2000
1652000
A2A adenosine receptors in human peripheral blood cells
S Gessi, K Varani, S Merighi, E Ongini, PA Borea
British journal of pharmacology 129 (1), 2-11, 2000
1552000
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor and interleukin-8 expression in hypoxic human colon cancer cells
S Merighi, A Benini, P Mirandola, S Gessi, K Varani, C Simioni, E Leung, ...
Molecular pharmacology, 2007
1472007
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells
S Merighi, P Mirandola, D Milani, K Varani, S Gessi, KN Klotz, E Leung, ...
Journal of Investigative Dermatology 119 (4), 923-933, 2002
1372002
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study
S Gessi, K Varani, S Merighi, E Cattabriga, V Iannotta, E Leung, ...
Molecular pharmacology 61 (2), 415-424, 2002
1322002
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils
K Varani, S Gessi, S Merighi, V Iannotta, E Cattabriga, S Spisani, ...
British journal of pharmacology 136 (1), 57-66, 2002
1262002
Adenosine signaling contributes to ethanol-induced fatty liver in mice
Z Peng, PA Borea, T Wilder, H Yee, L Chiriboga, MR Blackburn, G Azzena, ...
The Journal of clinical investigation 119 (3), 582-594, 2009
1232009
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives as human A3 adenosine receptor …
PG Baraldi, B Cacciari, S Moro, G Spalluto, G Pastorin, T Da Ros, ...
Journal of medicinal chemistry 45 (4), 770-780, 2002
1222002
Design, synthesis, and biological evaluation of a second generation of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidines as potent and selective A2A adenosine receptor …
PG Baraldi, B Cacciari, G Spalluto, M Bergonzoni, S Dionisotti, E Ongini, ...
Journal of medicinal chemistry 41 (12), 2126-2133, 1998
1211998
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 …
S Merighi, A Benini, P Mirandola, S Gessi, K Varani, E Leung, ...
Journal of Biological Chemistry 280 (20), 19516-19526, 2005
1192005
7-Substituted 5-amino-2-(2-furyl) pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at …
PG Baraldi, B Cacciari, R Romagnoli, G Spalluto, A Monopoli, E Ongini, ...
Journal of medicinal chemistry 45 (1), 115-126, 2002
1192002
Pyrazolo [4, 3-e] 1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists: influence of the chain at the N8 …
PG Baraldi, B Cacciari, R Romagnoli, G Spalluto, S Moro, KN Klotz, ...
Journal of medicinal chemistry 43 (25), 4768-4780, 2000
1192000
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists
PG Baraldi, MA Tabrizi, D Preti, A Bovero, R Romagnoli, F Fruttarolo, ...
Journal of medicinal chemistry 47 (6), 1434-1447, 2004
1182004
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells
S Merighi, A Benini, P Mirandola, S Gessi, K Varani, E Leung, ...
Biochemical pharmacology 72 (1), 19-31, 2006
1162006
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line
S Merighi, K Varani, S Gessi, E Cattabriga, V Iannotta, C Ulouglu, ...
British journal of pharmacology 134 (6), 1215-1226, 2001
1122001
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells
S Gessi, K Varani, S Merighi, A Morelli, D Ferrari, E Leung, PG Baraldi, ...
British journal of pharmacology 134 (1), 116-126, 2001
1122001
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as Highly Potent and Selective Human A3 Adenosine Receptor Antagonists
PG Baraldi, B Cacciari, R Romagnoli, G Spalluto, KN Klotz, E Leung, ...
Journal of medicinal chemistry 42 (22), 4473-4478, 1999
1061999
The system can't perform the operation now. Try again later.
Articles 1–20